title: Antidepressant-like effects of erythropoietin: a focus on behavioural and hippocampal processes.
abstract: Depression is a chronic and debilitating condition with a significant degree of relapse and treatment resistance that could stem, at least in part, from disturbances of neuroplasticity. This has led to an increased focus on treatment strategies that target brain derived neurotrophic factor (BDNF), synaptic plasticity and adult neurogenesis. In the current study we aimed to assess whether erythropoietin (EPO) would have antidepressant-like effects given its already established pro-trophic actions. In particular, we assessed whether EPO would diminish the deleterious effects of a social stressor in mice. Indeed, EPO induced anxiolytic and antidepressant-like responses in a forced swim test, open field, elevated-plus maze, and a novelty test, and appeared to blunt some of the negative behavioural effects of a social stressor. Furthermore, EPO promoted adult hippocampal neurogenesis, an important feature of effective antidepressants. Finally, a separate study using the mTOR inhibitor rapamycin revealed that antagonizing this pathway prevented the impact of EPO upon forced swim performance. These data are consistent with previous findings showing that the mTOR pathway and its neurogenic and synaptogenic effects might mediate the behavioral consequences of antidepressant agents. Our findings further highlight EPO as a possible adjunct treatment for affective disorders, as well as other stressor associated disorders of impaired neuroplasticity.
authors.affiliation: Department of Neuroscience, Carleton University, Ottawa, Ontario, Canada.
authors.forename: Meagan
authors.initials: M
authors.lastname: Osborn
authors.forename: Nazneen
authors.initials: N
authors.lastname: Rustom
authors.forename: Melanie
authors.initials: M
authors.lastname: Clarke
authors.forename: Darcy
authors.initials: D
authors.lastname: Litteljohn
authors.forename: Chris
authors.initials: C
authors.lastname: Rudyk
authors.forename: Hymie
authors.initials: H
authors.lastname: Anisman
authors.forename: Shawn
authors.initials: S
authors.lastname: Hayley
mesh_terms: D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects*; D004921:Erythropoietin / Q000494:pharmacology*; D006624:Hippocampus / Q000187:drug effects* / Q000502:physiology; D008297:Male; D018782:Maze Learning; D051379:Mice; D020123:Sirolimus / Q000494:pharmacology; D013550:Swimming
chemical_list: D000928:Antidepressive Agents; D004921:Erythropoietin; D020123:Sirolimus
references.citation: J Neurosci. 2002 Feb 1;22(3):635-8
references.pmid: 11826092
references.citation: Neuropsychopharmacology. 2008 Feb;33(3):611-8
references.pmid: 17473836
references.citation: Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4635-40
references.pmid: 9539790
references.citation: Trends Pharmacol Sci. 1999 Feb;20(2):59-61
references.pmid: 10101965
references.citation: Mol Cell Neurosci. 2008 Sep;39(1):118-24
references.pmid: 18620060
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30;34(4):645-51
references.pmid: 20227453
references.citation: Annu Rev Neurosci. 2006;29:507-38
references.pmid: 16776595
references.citation: Neuropsychopharmacology. 2008 Jan;33(2):406-17
references.pmid: 17429410
references.citation: Mol Psychiatry. 2008 Feb;13(2):119-21
references.pmid: 18202694
references.citation: Mol Psychiatry. 2009 Aug;14(8):764-73, 739
references.pmid: 18982002
references.citation: Cell Death Differ. 2008 Apr;15(4):783-92
references.pmid: 18259195
references.citation: Physiol Behav. 1996 Jan;59(1):153-6
references.pmid: 8848475
references.citation: Biol Psychiatry. 2006 Jun 15;59(12):1136-43
references.pmid: 16797263
references.citation: Neurosci Lett. 2008 Dec 31;448(3):245-9
references.pmid: 18973793
references.citation: Best Pract Res Clin Anaesthesiol. 2010 Dec;24(4):573-94
references.pmid: 21619868
references.citation: Neuropsychopharmacology. 2010 Nov;35(12):2378-91
references.pmid: 20686454
references.citation: Am J Psychiatry. 2000 Jan;157(1):115-8
references.pmid: 10618023
references.citation: Mol Psychiatry. 2007 Dec;12(12):1079-88
references.pmid: 17700574
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2003 Aug;27(5):729-39
references.pmid: 12921903
references.citation: J Neurosci. 2000 Dec 15;20(24):9104-10
references.pmid: 11124987
references.citation: Eur J Neurosci. 2004 Jul;20(1):229-39
references.pmid: 15245495
references.citation: J Neurosci. 2007 Mar 14;27(11):2788-92
references.pmid: 17360900
references.citation: Curr Opin Pharmacol. 2007 Feb;7(1):18-21
references.pmid: 17049922
references.citation: Nat Rev Neurosci. 2002 Jun;3(6):453-62
references.pmid: 12042880
references.citation: Brain. 2007 Oct;130(Pt 10):2577-88
references.pmid: 17728357
references.citation: Am J Psychiatry. 2003 Aug;160(8):1516-8
references.pmid: 12900317
references.citation: Neuropharmacology. 2011 Feb-Mar;60(2-3):354-64
references.pmid: 20932982
references.citation: Behav Processes. 2011 Jan;86(1):46-51
references.pmid: 20804831
references.citation: J Physiol. 2005 Dec 1;569(Pt 2):685-95
references.pmid: 16210356
references.citation: J Neurosci. 2009 May 27;29(21):6964-72
references.pmid: 19474323
references.citation: Brain Behav Immun. 2010 Mar;24(3):462-73
references.pmid: 20004715
references.citation: Neuropsychopharmacology. 2000 Feb;22(2):108-24
references.pmid: 10649824
references.citation: Brain Res. 2000 Dec 15;886(1-2):172-189
references.pmid: 11119695
references.citation: Psychopharmacology (Berl). 2009 Nov;207(1):133-42
references.pmid: 19705104
references.citation: Psychopharmacology (Berl). 2010 Jun;210(3):419-28
references.pmid: 20401747
references.citation: Hippocampus. 1992 Oct;2(4):431-5
references.pmid: 1308199
references.citation: Bipolar Disord. 2002 Jun;4(3):183-94
references.pmid: 12180273
references.citation: Neurobiol Dis. 2007 Jan;25(1):45-53
references.pmid: 17008107
references.citation: J Neurosci. 2002 Apr 15;22(8):3251-61
references.pmid: 11943826
references.citation: Biol Psychiatry. 2012 Aug 15;72(4):258-65
references.pmid: 22513055
references.citation: Int J Dev Neurosci. 1998 Jun-Jul;16(3-4):235-9
references.pmid: 9785120
references.citation: Brain Behav Immun. 2002 Oct;16(5):602-9
references.pmid: 12401475
references.citation: Biol Psychiatry. 2006 Jun 15;59(12):1116-27
references.pmid: 16631126
references.citation: Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1387-92
references.pmid: 12552118
references.citation: Neuropharmacology. 2012 Jan;62(1):35-41
references.pmid: 21907221
references.citation: Brain Res Bull. 2011 Nov 25;86(5-6):454-9
references.pmid: 21864655
references.citation: Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3168-71
references.pmid: 9501234
references.citation: Behav Brain Res. 2012 Apr 21;230(1):78-84
references.pmid: 22326698
references.citation: Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):3908-13
references.pmid: 8632988
references.citation: Science. 2010 Aug 20;329(5994):959-64
references.pmid: 20724638
references.citation: J Neurosci. 1994 Sep;14(9):5373-80
references.pmid: 8083742
references.citation: Trials. 2010 Oct 13;11:97
references.pmid: 20942940
references.citation: Behav Brain Res. 2006 Mar 15;168(1):127-36
references.pmid: 16324754
references.citation: Cytokine. 2013 Jan;61(1):329-35
references.pmid: 23148990
references.citation: J Comp Neurol. 2009 Jun 1;514(4):403-14
references.pmid: 19330822
references.citation: Psychopharmacology (Berl). 2012 Feb;219(3):687-98
references.pmid: 21947319
references.citation: Am J Psychiatry. 2004 Apr;161(4):598-607
references.pmid: 15056502
references.citation: J Pharmacol Exp Ther. 2006 Oct;319(1):44-52
references.pmid: 16807359
references.citation: Psychiatry Res. 2004 Dec 15;132(2):141-7
references.pmid: 15598548
references.citation: Biol Psychiatry. 2009 Aug 1;66(3):267-74
references.pmid: 19185286
references.citation: Pharm Res. 1998 Apr;15(4):576-82
references.pmid: 9587954
references.citation: J Neurosci. 1996 May 15;16(10):3534-40
references.pmid: 8627386
references.citation: Mol Psychiatry. 2000 May;5(3):262-9
references.pmid: 10889528
references.citation: J Neurosurg. 2010 Sep;113(3):598-608
references.pmid: 19817538
references.citation: Biol Psychiatry. 1999 Nov 1;46(9):1181-91
references.pmid: 10560024
references.citation: Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15506-11
references.pmid: 15483108
references.citation: Metab Brain Dis. 1997 Dec;12(4):271-80
references.pmid: 9475500
references.citation: J Neurosci Res. 2002 Mar 15;67(6):795-803
references.pmid: 11891794
references.citation: Science. 2003 Aug 8;301(5634):805-9
references.pmid: 12907793
references.citation: Biochem Biophys Res Commun. 1998 Dec 9;253(1):26-32
references.pmid: 9875214
references.citation: Annu Rev Neurosci. 1999;22:105-22
references.pmid: 10202533
references.citation: Pharmacol Ther. 2006 May;110(2):135-370
references.pmid: 16522330
references.citation: Biol Psychiatry. 2007 Dec 1;62(11):1244-50
references.pmid: 17553466
references.citation: Curr Med Chem. 2011;18(28):4359-67
references.pmid: 21861813